Literature DB >> 34968493

Per- and polyfluoroalkyl substances target and alter human prostate stem-progenitor cells.

Wen-Yang Hu1, Ranli Lu2, Dan Ping Hu2, Ozan Berk Imir3, Qianying Zuo4, Dan Moline5, Parivash Afradiasbagharani2, Lifeng Liu2, Scott Lowe6, Lynn Birch2, Donald J Vander Griend7, Zeynep Madak-Erdogan8, Gail S Prins9.   

Abstract

Per- and polyfluorinated alkyl substances (PFAS) are a large family of widely used synthetic chemicals that are environmentally and biologically persistent and present in most individuals. Chronic PFAS exposure have been linked to increased prostate cancer risk in occupational settings, however, underlying mechanisms have not been interrogated. Herein we examined exposure of normal human prostate stem-progenitor cells (SPCs) to 10 nM PFOA or PFOS using serial passage of prostasphere cultures. Exposure to either PFAS for 3-4 weeks increased spheroid numbers and size indicative of elevated stem cell self-renewal and progenitor cell proliferation. Transcriptome analysis using single-cell RNA sequencing (scRNA-seq) showed 1) SPC expression of PPARs and RXRs able to mediate PFAS effects, 2) the emergence of a new cell cluster of aberrantly differentiated luminal progenitor cells upon PFOS/PFOA exposure, and 3) enrichment of cancer-associated signaling pathways. Metabolomic analysis of PFAS-exposed prostaspheres revealed increased glycolytic pathways including the Warburg effect as well as strong enrichment of serine and glycine metabolism which may promote a pre-malignant SPC fate. Finally, growth of in vivo xenografts of tumorigenic RWPE-2 human prostate cells, shown to contain cancer stem-like cells, was markedly enhanced by daily PFOS feeding to nude mice hosts. Together, these findings are the first to identify human prostate SPCs as direct PFAS targets with resultant reprogrammed transcriptomes and metabolomes that augment a preneoplastic state and may contribute to an elevated prostate cancer risk with chronic exposures.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PFAS; PFOA; PFOS; Progenitor cell; Prostate; Stem cell

Mesh:

Substances:

Year:  2021        PMID: 34968493      PMCID: PMC8890783          DOI: 10.1016/j.bcp.2021.114902

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  57 in total

Review 1.  Sources, fate and transport of perfluorocarboxylates.

Authors:  Konstantinos Prevedouros; Ian T Cousins; Robert C Buck; Stephen H Korzeniowski
Journal:  Environ Sci Technol       Date:  2006-01-01       Impact factor: 9.028

2.  Constant Degradation of the Androgen Receptor by MDM2 Conserves Prostate Cancer Stem Cell Integrity.

Authors:  Premkumar Vummidi Giridhar; Karin Williams; Andrew P VonHandorf; Paul L Deford; Susan Kasper
Journal:  Cancer Res       Date:  2019-01-09       Impact factor: 12.701

3.  Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.

Authors:  Markus Germann; Antoinette Wetterwald; Natalia Guzmán-Ramirez; Gabri van der Pluijm; Zoran Culig; Marco G Cecchini; Elizabeth D Williams; George N Thalmann
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

4.  Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.

Authors:  D Bello; M M Webber; H K Kleinman; D D Wartinger; J S Rhim
Journal:  Carcinogenesis       Date:  1997-06       Impact factor: 4.944

5.  Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4.

Authors:  Shuk-Mei Ho; Wan-Yee Tang; Jessica Belmonte de Frausto; Gail S Prins
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

6.  Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.

Authors:  Xin Chen; Qiuhui Li; Xin Liu; Can Liu; Ruifang Liu; Kiera Rycaj; Dingxiao Zhang; Bigang Liu; Collene Jeter; Tammy Calhoun-Davis; Kevin Lin; Yue Lu; Hsueh-Ping Chao; Jianjun Shen; Dean G Tang
Journal:  Clin Cancer Res       Date:  2016-04-08       Impact factor: 12.531

7.  Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification.

Authors:  Shuk-Mei Ho; Ana Cheong; Hung-Ming Lam; Wen-Yang Hu; Guang-Bin Shi; Xuegong Zhu; Jing Chen; Xiang Zhang; Mario Medvedovic; Yuet-Kin Leung; Gail S Prins
Journal:  Endocrinology       Date:  2015-08-06       Impact factor: 4.736

8.  In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells.

Authors:  John K Blackwood; Stuart C Williamson; Laura C Greaves; Laura Wilson; Anastasia C Rigas; Raveen Sandher; Robert S Pickard; Craig N Robson; Douglass M Turnbull; Robert W Taylor; Rakesh Heer
Journal:  J Pathol       Date:  2011-10       Impact factor: 7.996

9.  Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.

Authors:  Joshi J Alumkal; Duanchen Sun; Eric Lu; Tomasz M Beer; George V Thomas; Emile Latour; Rahul Aggarwal; Jeremy Cetnar; Charles J Ryan; Shaadi Tabatabaei; Shawna Bailey; Claire B Turina; David A Quigley; Xiangnan Guan; Adam Foye; Jack F Youngren; Joshua Urrutia; Jiaoti Huang; Alana S Weinstein; Verena Friedl; Matthew Rettig; Robert E Reiter; Daniel E Spratt; Martin Gleave; Christopher P Evans; Joshua M Stuart; Yiyi Chen; Felix Y Feng; Eric J Small; Owen N Witte; Zheng Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-18       Impact factor: 11.205

View more
  3 in total

Review 1.  Toward a Mechanistic Understanding of Poly- and Perfluoroalkylated Substances and Cancer.

Authors:  Raya I Boyd; Saeed Ahmad; Ratnakar Singh; Zeeshan Fazal; Gail S Prins; Zeynep Madak Erdogan; Joseph Irudayaraj; Michael J Spinella
Journal:  Cancers (Basel)       Date:  2022-06-14       Impact factor: 6.575

2.  Targeting Metabolic Adaptations in the Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy.

Authors:  Qianying Zuo; Ayca Nazli Mogol; Yu-Jeh Liu; Ashlie Santaliz Casiano; Christine Chien; Jenny Drnevich; Ozan Berk Imir; Eylem Kulkoyluoglu-Cotul; Nicole Hwajin Park; David J Shapiro; Ben Ho Park; Yvonne Ziegler; Benita S Katzenellenbogen; Evelyn Aranda; John D O'Neill; Akshara Singareeka Raghavendra; Debu Tripathy; Zeynep Madak Erdogan
Journal:  Mol Cancer Res       Date:  2022-06-03       Impact factor: 6.333

3.  Low Doses of PFOA Promote Prostate and Breast Cancer Cells Growth through Different Pathways.

Authors:  Aurélie Charazac; Charlotte Hinault; Bastien Dolfi; Solène Hautier; Célia Decondé Le Butor; Frédéric Bost; Nicolas Chevalier
Journal:  Int J Mol Sci       Date:  2022-07-18       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.